Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[HIV-associated pulmonary hypertension ].

Georg Friese1, Jürgen Lohmeyer, Werner Seeger

  • 1Medizinische Klinik II/V, Universitätsklinikum Giessen, Klinikstrasse 36, 35392, Giessen. georg.friese@innere.med.uni-giessen.de

Herz
|September 20, 2005
PubMed
Summary

Pulmonary hypertension (PH) is 1,000 times more common in HIV patients. Early diagnosis of PH in HIV-infected individuals is crucial for effective management and improved outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial proteomics profiling reveals oncogene-specific immune niches and prognostic markers in NSCLC.

American journal of respiratory and critical care medicine·2026
Same author

IRG1/itaconate rewires macrophage and lung tumor metabolism through G6PD inhibition.

Cell metabolism·2026
Same author

Diagnostic yield and histopathological assessment of endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy: a prospective comparison of two tunnelling approaches.

ERJ open research·2026
Same author

Case Report: Tezepelumab as rescue therapy in near-fatal asthma requiring extracorporeal membrane oxygenation.

Frontiers in immunology·2026
Same author

Divergent CD45<sup>+</sup> immune landscapes shape the lung tumor microenvironment.

Frontiers in immunology·2026
Same author

Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment.

EBioMedicine·2025

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pulmonology

Context:

  • Pulmonary hypertension (PH) is a severe, life-limiting condition, particularly impacting younger individuals.
  • A well-documented link exists between Human Immunodeficiency Virus (HIV) infection and the development of PH, though the exact pathobiology remains elusive.
  • Advances in highly active antiretroviral therapy (HAART) have improved HIV prognosis, making PH a significant life-limiting factor for these patients.

Purpose:

  • To highlight the increased incidence of pulmonary hypertension in HIV-infected individuals.
  • To emphasize the importance of screening HIV patients with exercise-induced dyspnea for PH, after excluding other cardiopulmonary disorders.
  • To underscore the necessity of early and accurate diagnosis due to emerging therapeutic options.

Summary:

Related Experiment Videos

  • The incidence of PH is approximately 1,000 times higher in HIV patients compared to the general population.
  • Noninvasive methods like echocardiography can support a suspected PH diagnosis, but right heart catheterization is the gold standard.
  • New treatments including prostanoids, endothelin antagonists, and phosphodiesterase-5 inhibitors necessitate timely diagnosis.

Impact:

  • Early detection of PH in HIV patients can lead to timely intervention and management.
  • Improved diagnostic strategies can enhance the quality of life for HIV patients affected by PH.
  • Further research into the pathobiology of HIV-associated PH is warranted to develop targeted therapies.